cytarabine has been researched along with Muscular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selleslag, D | 1 |
| Cuevas, J; Cummings, L; Eaton, A; Elshire, D; Fu, JC; Moyer, DL | 1 |
2 other study(ies) available for cytarabine and Muscular Diseases
| Article | Year |
|---|---|
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |
Response of intramuscular Walker 256 rat tumor to sustained-release cyclophosphamide and ARA-C capsules.
Topics: Animals; Capsules; Carcinoma 256, Walker; Cyclophosphamide; Cytarabine; Delayed-Action Preparations; Muscular Diseases; Rats; Remission, Spontaneous; Silicone Elastomers | 1978 |